Dynamic alterations of VEGF and intervention of its expression on effect of hepatocyte malignant transformation

National Medical Journal of China

Volumn 90, Issue 42, 2010, Pages 3014-3018

  Yao, Deng Fu ^a   Qiu, Li Wei ^a   Wu, Wei ^a   Yao, Ning Hua ^a   Li, Shan Shan ^a   Bian, Yin Zhu ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Intervention; VEGF; Western blot

Indexed keywords

N (2 FLUORENYL)ACETAMIDE; THALIDOMIDE; VASCULOTROPIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; DENATURATION; IMMUNOHISTOCHEMISTRY; INTERVENTION STUDY; LIVER; LIVER CELL; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; LIVER TUMOR; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; HEPATOCYTES; LIVER NEOPLASMS; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871422670     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.42.017     Document Type: Article

References (16)

1. Kaseb A O, Hanbali A, Cotant M, et al. Vascular endothelial growth factor in the management of hepatocellular carcinoma; a review of literature. Cancer, 2009, 115:4895-4906.
2. Schoenleber S J, Kurtz D M, Talwalkar J A, et al. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma; systematic review and meta-analysis. Br J Cancer, 2009, 100: 1385-1392.
3. Fernandez M, Semela D, Bruix J, et al. Angiogenesis in liver disease. J Hepatol, 2009, 50: 604-620.
4. Yao DF, Wu XH, Zhu Y, et al. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 2005, 4: 220-226.
5. 2004, 12: 92-94.
6. Zeng W, Gouw A S, van den Heuvel M C, et al. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Hepatology, 2008, 48: 1517-1527.
7. Dai C X, Gao Q, Qiu S J, et al. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer, 2009, 9: 418.
8. Tamesa T, Iizuka N, Mori N, et al. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma. Hepatogastroenterology, 2009, 56: 1122-1126.
9. Huynh H, Ngo V C, Fargnoli J, et al. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Clin Cancer Res, 2008, 14: 6146-6153.
10. Jain S, Singhal S, Lee P, et al. Molecular genetics of hepatocellular neoplasia. Am J Transl Res, 2010, 2: 105-118.
11. Yao D F, Jiang H, Yao M, et al. Quantitative analysis of hepatic hypoxia-inducible factor-1 alpha and its gene abnormal expression during the formation of hepato-cellular carcinoma. Hepatobiliary Pancreat Dis Int, 2009, 8: 407-413.
12. Pinter M, Wichlas M, Schmid K, et al. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial. Eur J Gastroenterol Hepatol, 2008, 20:1012-1019.
13. Finn R S, Zhu A X. Targeting angiogenesis in hepatocellular carcinoma; focus on VEGF and bevacizumab. Expert Rev Anticancer Ther, 2009, 9: 503-509.
14. 2006, 86: 2803-2805.
15. Dong Z Z, Yao D F, Wu W, et al. Delated hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-K appa B activation pathway in rats. Hepatobliary Pancreat Dis Int, 2010, 9: 169-174.
16. Chen G, Wang Y, Zhou M, et al. EphAl receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma. Oncol Rep, 2010, 23: 563-570.